The Hearty Soul on MSN
New Treatment for Chronic Kidney Disease Discovered, Scientists
Scientists have discovered new chronic kidney disease treatment options in 2025-2026, from finerenone for non-diabetic CKD to ...
The United States Food and Drug Administration (US FDA) has approved Trutakna (atacicept-vymj), a first-in-class treatment ...
The FDA approved a new medicine from the biotech company Vera Therapeutics for patients with a type of chronic autoimmune ...
Shares of Vera Therapeutics rose about 8% Tuesday after the Food and Drug Administration approved its treatment for a kidney ...
The National Institute for Health and Care Excellence (NICE) has recommended sparsentan (Filspari, Vifor Pharma) for treating primary immunoglobulin A nephropathy in adults. The recommendation ...
The milestone marks a significant step forward for a technology designed to address one of healthcare's most persistent challenges. Millions of patients worldwide rely on treatments that primarily ...
HOUSTON — The nonsteroidal mineralocorticoid-receptor antagonist drug finerenone led to significant reductions in albuminuria in patients with type 1 diabetes (T1D) and chronic kidney disease (CKD) ...
MedPage Today on MSN
Treatment Horizon Expanding for Focal Segmental Glomerulosclerosis
New drugs, dietary changes can help reduce proteinuria ...
MedPage Today on MSN
Chronic Kidney Disease Increasingly Driven By Diabetes
Despite treatment advances, kidney disease burden remained unchanged over the past decade ...
Three years after receiving a life-saving kidney transplant, Blackfoot native Adrian Ropp found himself walking the halls of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results